Steven Cohen’s Twist Bioscience TWST Stock Holding History

Steven Cohen’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-669,732	Closed	-$31.8M	–	4599
2026 Q1	$31.8M	Buy	+669,732	New	+$30M	0.04%	580
2025 Q4	–	Sell	-530,032	Closed	-$14.9M	–	4181
2025 Q3	$14.9M	Sell	530,032 -1,628,357	-75%	-$49.3M	0.03%	655
2025 Q2	$79.4M	Buy	2,158,389 +725,537	+51%	+$25.1M	0.16%	155
2025 Q1	$56.3M	Buy	+1,432,852	New	+$64.5M	0.13%	192
2024 Q3	–	Sell	-673,057	Closed	-$33.2M	–	2358
2024 Q2	$33.2M	Buy	+673,057	New	+$27.4M	0.09%	299
2023 Q4	–	Sell	-7,774	Closed	-$180K	–	2840
2023 Q3	$158K	Buy	+7,774	New	+$171K	﹤0.01%	1824
2023 Q1	–	Sell	-547,500	Closed	-$13M	–	2544
2022 Q4	$13M	Buy	547,500 +415,367	+314%	+$12M	0.04%	464
2022 Q3	$4.66M	Buy	+132,133	New	+$5.61M	0.02%	747
2022 Q2	–	Sell	-18,340	Closed	-$906K	–	1645
2022 Q1	$906K	Buy	+18,340	New	+$1.02M	﹤0.01%	974

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Steven Cohen's TWST Position: Q2 2026 in Review

Steven Cohen sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 669,732 shares — an estimated $31.8M sold.

Steven Cohen first reported a position in TWST in Q1 2022 and held it in 9 quarters. The position peaked at $79.4M in Q2 2025. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Steven Cohen reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 669,732 Twist Bioscience shares in Q2 2026, an estimated $31.8M.
Steven Cohen first reported a position in Twist Bioscience in Q1 2022 and held it in 9 quarters.
Steven Cohen's Twist Bioscience position peaked at $79.4M in Q2 2025.
334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.